EPRONTIA™已被批准作为单一疗法,用于治疗2岁及以上患者的部分发作或原发性全身强直-阵挛发作;作为辅助疗法,用...查看全文
美港电讯APP2021-08-06 16:28
$Eton Pharmaceuticals(ETON)$ 盘前涨10.4%,美国食品药品监督管理局(FDA)今日将审核是否批准Eton Pharmaceuticals治疗癫痫的口服新药。(来自美港电讯APP)查看全文
$Eton Pharmaceuticals(ETON)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-21-014667 Size: 7 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-21-014444 Act: 34 Size: 44 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-21-014410 Act: 34 Size: 39 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-21-013513 Size: 5 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 8-K Current report, item 8.01 Accession Number: 0001493152-21-013245 Act: 34 Size: 29 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-21-013152 Act: 34 Size: 38 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 内部交易: 2021-05-27,10% Owner,Opaleye Management Inc. ,卖出,126000普通股, $8.49
$Eton Pharmaceuticals(ETON)$ 内部交易: 2021-05-26,10% Owner,Opaleye Management Inc. ,卖出,68300普通股, $8.57
$Eton Pharmaceuticals(ETON)$ 内部交易: 2021-05-25,10% Owner,Opaleye Management Inc. ,卖出,48000普通股, $8.53
$Eton Pharmaceuticals(ETON)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-21-013107 Size: 13 KB 网页链接